[1]
B. Mofid, “Oncological Outcomes of Neoadjuvant Gemcitabine plus Carboplatin versus Gemcitabine plus Cisplatin in Locally Advanced Bladder Cancer: A Retrospective Analysis: Neoadjuvant carboplatin in locally advanced bladder cancer”, Urol J, vol. 19, no. 05, pp. 371–378, Nov. 2022.